May 27, 2020 (Market Insight Reports) -- The Global Veterinary Diagnostics Market report offers a comprehensive analysis of the Global market. This report focused on market past and present growth Globally. Global research on Global Veterinary Diagnostics Industry presents a market overview, product details, classification, market concentration, and maturity study. The market value and growth rate from 2019-2025 along with industry size estimates are explained.
The global veterinary diagnostics market accounted for around 22% of the entire veterinary healthcare market. Veterinary diagnostics has potential applications in the diagnosis and management of several animal diseases, such as foot-and-mouth disease, classical swine fever, avian flu, and bovine spongiform encephalopathy, etc. This factor is fuelling the market in spite of hindrances like shortage of veterinarians in emerging markets.
The market is expected to register a CAGR of 7.91% by 2023, with a 55% increase in the overall market, during 2018-2023 (the forecast period).
Request for PDF Brochure
Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including-
Abaxis, Henry Schein, Heska Corporation, Idvet, Pfizer, Thermo Fisher Scientific, Virbac, Zoetis
Market segment by Regions/Countries, this report covers
North America (U.S., Global, Mexico)
Global (Germany, UK, France, Rest of Global)
Asia Pacific (China, India, Japan, Rest of Asia Pacific)
Latin America (Brazil, Argentina, Rest of Latin America)
Middle East & Africa
Market Research Analysis:
PHAROS DIAGNOSTICS EXPANDS INTO VETERINARY DIAGNOSTICS MARKET
From 2017, Pharos diagnostics is expanding into Veterinary diagnostics. It will be among the first diagnostic laboratories to offer mass spectrometry into the Veterinary diagnostics market, which is widely regarded as the most accurate and sensitive scientific method for measuring drugs, hormones, and other analytics in, both, humans and animals. Technology improvements of the last decade, like mass spectrometry, have not completely entered the veterinary diagnostic market, especially, when compared to human medicine. Traditionally, veterinarians had to choose between expensive, slow, and sometimes inaccurate testing options while performing testing. The expansion of Pharos in Veterinary diagnostics is anticipated to change the scenario. The key benefits to the veterinary market will be increased accuracy in testing, with faster turnaround time, coupled with cost-efficiency. The mass spectrometer platform, employed by Pharos diagnostics, allows multiple tests to be performed using the same sample. Since smaller samples can often be obtained using less intrusive methods, there would be less hassle for the veterinarian and a better experience for the consumer.
UNTAPPED EMERGING MARKETS TO BE THE PRIMARY FOCUS OF MAJOR MARKET PLAYERS
The North American and European Veterinary diagnostics markets have large shares, owing to the increasing companion animal population, coupled with the positive trend towards animal healthcare spending. Developing countries in Asia-pacific and South America are expected to form a new revenue generator in the market, with India, China, and Brazil occupying major market share over the next decade.
Read Detailed Index of full Research Study at:
Major points covered in this research are:-
Veterinary Diagnostics Market Overview, Segment by Type (Product Category), by Application, by Region (2019-2023), Competition by Manufacturers
Global Market Size (Value) of Veterinary Diagnostics (2019-2023)
Global Veterinary Diagnostics Capacity, Production, Revenue (Value), Supply (Production), Consumption, Export, Import by Region (2019-2015)
Global Veterinary Diagnostics Production, Revenue (Value), Price Trend by Type